Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 827CNS 115Thoracic 96Sarcoma 79Other solid neoplasm 75Tumor-Agnostic 40Breast 34Gynecologic 24Genitourinary 21Lymphoid 13Dermatologic 10Other hematologic neoplasm 9Head & Neck 9Endocrine 9NET 3Plasma cell 1Other neoplasm 1Myeloid 1Classical hematology 1

Conditions

Thrombocytopenia 1Colorectal Neoplasms 1

Interventions

Cyclophosphamide 94fludarabine phosphate 87Busulfan 64Cyclosporine 57Epoetin Alfa 55Peripheral Blood Stem Cell Transplantation 54Mycophenolic Acid 54Whole-Body Irradiation 53fludarabine 45Antilymphocyte Serum 43Filgrastim 41Cytarabine 41Melphalan 40Tacrolimus 39Darbepoetin alfa 39Methotrexate 34Radiotherapy 33Cord Blood Stem Cell Transplantation 28Granulocyte Colony-Stimulating Factor 23apixaban 22Methylprednisolone 22Rivaroxaban 21Etoposide 21Thiotepa 17Dalteparin 17eltrombopag 16ferric carboxymaltose 14epoetin beta 14Daunorubicin 14Azacitidine 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Irinotecan × Classical hematology × Clear all
NCT03823079 2019-01-30

Comparison of Interleukin-11 and rhTPO for Recurrent Colorectal Cancer Patients With Thrombocytopenia

Fudan University

Phase 2 Unknown
50 enrolled
Classical hematologyGastrointestinal

Thrombocytopenia, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡